Form 4 for TXG 10x Genomics, Inc.
Accepted 2022-01-14 00:00:00 ET · period of report 2022-01-12 · accession 0001567619-22-001197 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-14 | 2022-01-12 | TXG | CRUTCHFIELD BRADFORD | Chief Commercial Off | S - Sale+OE | $119.00 | -17.0K | 101.2K | -14% | -$2.02M |
| D | 2022-01-14 | 2022-01-12 | TXG | CRUTCHFIELD BRADFORD | Chief Commercial Off | M - OptEx | $1.16 | +17.0K | 114.7K | +17% | +$19.7K |
| D | 2022-01-14 | 2022-01-12 | TXG | CRUTCHFIELD BRADFORD | Chief Commercial Off | M - OptEx | $0.00 | -17.0K | 409.0K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-01-12 | S | D | 5,185 | $118.32 | 103,273 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $117.90 to $118.84. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2022-01-12 | S | D | 1,017 | $119.28 | 102,256 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $118.985 to $119.83. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2022-01-12 | S | D | 3,200 | $121.77 | 97,956 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $121.47 to $122.35. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2022-01-12 | S | D | 100 | $122.94 | 97,856 | D | — | — | |
| 5 | Common | Class A Common Stock | 2022-01-12 | S | D | 100 | $123.53 | 97,756 | D | — | — | |
| 6 | Common | Class A Common Stock | 2022-01-12 | S | D | 100 | $124.44 | 97,656 | D | — | — | |
| 7 | Common | Class A Common Stock | 2022-01-12 | S | D | 3 | $125.00 | 97,653 | D | — | — | |
| 8 | Common | Class A Common Stock | 2022-01-12 | S | D | 6,195 | $117.53 | 108,458 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $116.89 to $117.87. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 9 | Common | Class A Common Stock | 2022-01-12 | M | A | 17,000 | $1.16 | 114,653 | D | — | — | |
| 10 | Common | Class A Common Stock | 2022-01-12 | S | D | 1,100 | $120.93 | 101,156 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $120.31 to $121.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 11 | Derivative | Stock Option (right to buy) | 2022-01-12 | M | D | 17,000 | $0.00 | 409,000 | D | $1.16 · — to 2027-02-03 | 17,000 Class A Common Stock | (F7) This option, originally for 800,000 shares, of which 391,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |